Peter Hosein

Associate Professor of Clinical

  • Source: Scopus
20082021

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Peter Hosein is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 12 Similar Profiles

Network

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
  • The prevalence and clinical relevance of 2R/2R TYMS genotype in patients with gastrointestinal malignancies treated with fluoropyrimidine-based chemotherapy regimens

    Khushman, M., Patel, G. K., Maharjan, A. S., McMillin, G. A., Nelson, C., Hosein, P. & Singh, A. P., Jun 2021, In: Pharmacogenomics Journal. 21, 3, p. 308-317 10 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
  • DNA damage repair deficiency as a predictive biomarker for FOLFIRINOX efficacy in metastatic pancreatic cancer

    Palacio, S., McMurry, H. S., Ali, R., Donenberg, T., Silva-Smith, R., Wideroff, G., Sussman, D. A., Lima, C. M. S. R. & Hosein, P. J., Dec 1 2019, In: Journal of Gastrointestinal Oncology. 10, 6, p. 1133-1139 7 p.

    Research output: Contribution to journalArticlepeer-review

    5 Scopus citations
  • Does Neoadjuvant Chemotherapy Change the Role of Regional Lymphadenectomy in Pancreatic Cancer Survival?

    Macedo, F. I., Picado, O., Hosein, P., Dudeja, V., Franceschi, D., Mesquita-Neto, J. W., Yakoub, D. & Merchant, N., Jul 1 2019, In: Pancreas. 48, 6, p. 823-831 9 p.

    Research output: Contribution to journalArticlepeer-review

    2 Scopus citations
  • Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib

    Hammel, P., Kindler, H. L., Reni, M., Van Cutsem, E., MacArulla, T., Hall, M. J., Park, J. O., Hochhauser, D., Arnold, D., Oh, D. Y., Reinacher-Schick, A., Tortora, G., Algül, H., O'Reilly, E. M., McGuinness, D., Cui, K. Y., Joo, S., Yoo, H. K., Patel, N., Golan, T. & 127 others, Chantrill, L., Goldstein, D., Joubert, W., Pavlakis, N., Tognela, A., Van Cutsem, E., Van Fraeyenhove, F., Van Laethem, J. L., Peeters, M., Dhani, N., Kavan, P., Lemay, F., Adenis, A., Artru, P., Baba-Hamed, N., Belletier, C., Ben Abdelghani, M., Blanc, J. F., Borg, C., Coriat, R., Deplanque, G., Faroux, R., Follana, P., Guimbaud, R., El Hajbi, F., Hammel, P., Hautefeuille, V., Malka, D., Metges, J. P., Tougeron, D., Walter, T., Ettrich, T., Hacker, U. T., Hennes, E., Jacobasch, L., Kanzler, S., Pession, U., Scholz, C., Sinn, M., Stein, A., Strassburg, C., Vogel, A., Ben-Shahar, M., Brenner, R., Epelbaum, R., Geva, R., Gluzman, A., Golan, T., Idelevich, E., Kolin, M., Semenisty, V., Shai, A., Stemmer, S., Yarom, N., Celio, L., Conte, P., Garufi, C., Gianni, L., Leonardi, F., Maiello, E., Di Marco, M., Milella, M., Pinto, C., Santini, D., Scartozzi, M., Vaccaro, V., Vasile, E., Kim, J. W., Kim, J. W., Oh, D. Y., Oh Park, J., Wilmink, H., Gallego, R. A., Ogalla, G. D., Velasco, A. G., Cabanas, E. G., Gomez Martin, C., Ponce, C. G., Saez, B. L., Lopez, R., MacArulla, T., Martin, A. M., Pazo, R., Pijaume, C. P., Rodriguez, J., Yaya-Tur, R., Arora, A., Anthoney, D. A., Jeffrey Evans, T. R., Harrison, M., Hochhauser, D., Palmer, D., Sarker, D., Starling, N., Valle, J., Wall, L., Agajanian, R., Bearden, J., Bekaii-Saab, T., Carter, C., Cohen, D., Distefano, A., Dragovich, T., Ejadi, S., Ford, J., Grabelsky, S., Hall, M., Hochster, H., Hosein, P., Javle, M., Kindler, H., Lacy, J., Laheru, D., Leong, S., Lowery, M., Marsh, R., Noonan, A., Oberstein, P., Ocean, A., O'Reilly, E., Ryan, D., Seery, T., Subramaniam, S., Van Echo, D., Wang-Gillam, A., Weekes, C. & Welch, S., Dec 1 2019, In: Annals of Oncology. 30, 12, p. 1959-1968 10 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    11 Scopus citations
  • Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: A systematic review and patient-level meta-analysis

    Janssen, Q. P., Buettner, S., Suker, M., Beumer, B. R., Addeo, P., Bachellier, P., Bahary, N., Bekaii-Saab, T., Bali, M. A., Besselink, M. G., Boone, B. A., Chau, I., Clarke, S., Dillhoff, M., El-Rayes, B. F., Frakes, J. M., Grose, D., Hosein, P. J., Jamieson, N. B., Javed, A. A. & 28 others, Khan, K., Kim, K. P., Kim, S. C., Kim, S. S., Ko, A. H., Lacy, J., Margonis, G. A., McCarter, M. D., McKay, C. J., Mellon, E. A., Moorcraft, S. Y., Okada, K. I., Paniccia, A., Parikh, P. J., Peters, N. A., Rabl, H., Samra, J., Tinchon, C., van Tienhoven, G., van Veldhuisen, E., Wang-Gillam, A., Weiss, M. J., Wilmink, J. W., Yamaue, H., Homs, M. Y. V., van Eijck, C. H. J., Katz, M. H. G. & Koerkamp, B. G., Aug 1 2019, In: Journal of the National Cancer Institute. 111, 8, p. 782-794 13 p.

    Research output: Contribution to journalReview articlepeer-review

    58 Scopus citations